BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 30668141)

  • 1. MBD3/NuRD loss participates with KDM6A program to promote DOCK5/8 expression and Rac GTPase activation in human acute myeloid leukemia.
    Biswas M; Chatterjee SS; Boila LD; Chakraborty S; Banerjee D; Sengupta A
    FASEB J; 2019 Apr; 33(4):5268-5286. PubMed ID: 30668141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SMARCB1 Deficiency Integrates Epigenetic Signals to Oncogenic Gene Expression Program Maintenance in Human Acute Myeloid Leukemia.
    Chatterjee SS; Biswas M; Boila LD; Banerjee D; Sengupta A
    Mol Cancer Res; 2018 May; 16(5):791-804. PubMed ID: 29483235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KDM6 demethylases integrate DNA repair gene regulation and loss of KDM6A sensitizes human acute myeloid leukemia to PARP and BCL2 inhibition.
    Boila LD; Ghosh S; Bandyopadhyay SK; Jin L; Murison A; Zeng AGX; Shaikh W; Bhowmik S; Muddineni SSNA; Biswas M; Sinha S; Chatterjee SS; Mbong N; Gan OI; Bose A; Chakraborty S; Arruda A; Kennedy JA; Mitchell A; Lechman ER; Banerjee D; Milyavsky M; Minden MD; Dick JE; Sengupta A
    Leukemia; 2023 Apr; 37(4):751-764. PubMed ID: 36720973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The proto-oncoprotein FBI-1 interacts with MBD3 to recruit the Mi-2/NuRD-HDAC complex and BCoR and to silence p21WAF/CDKN1A by DNA methylation.
    Choi WI; Jeon BN; Yoon JH; Koh DI; Kim MH; Yu MY; Lee KM; Kim Y; Kim K; Hur SS; Lee CE; Kim KS; Hur MW
    Nucleic Acids Res; 2013 Jul; 41(13):6403-20. PubMed ID: 23658227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutralizing Gatad2a-Chd4-Mbd3/NuRD Complex Facilitates Deterministic Induction of Naive Pluripotency.
    Mor N; Rais Y; Sheban D; Peles S; Aguilera-Castrejon A; Zviran A; Elinger D; Viukov S; Geula S; Krupalnik V; Zerbib M; Chomsky E; Lasman L; Shani T; Bayerl J; Gafni O; Hanna S; Buenrostro JD; Hagai T; Masika H; Vainorius G; Bergman Y; Greenleaf WJ; Esteban MA; Elling U; Levin Y; Massarwa R; Merbl Y; Novershtern N; Hanna JH
    Cell Stem Cell; 2018 Sep; 23(3):412-425.e10. PubMed ID: 30122475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disruption of the MBD2-NuRD complex but not MBD3-NuRD induces high level HbF expression in human adult erythroid cells.
    Yu X; Azzo A; Bilinovich SM; Li X; Dozmorov M; Kurita R; Nakamura Y; Williams DC; Ginder GD
    Haematologica; 2019 Dec; 104(12):2361-2371. PubMed ID: 31004025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MBD3/NuRD facilitates induction of pluripotency in a context-dependent manner.
    dos Santos RL; Tosti L; Radzisheuskaya A; Caballero IM; Kaji K; Hendrich B; Silva JC
    Cell Stem Cell; 2014 Jul; 15(1):102-10. PubMed ID: 24835571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MBD2/NuRD and MBD3/NuRD, two distinct complexes with different biochemical and functional properties.
    Le Guezennec X; Vermeulen M; Brinkman AB; Hoeijmakers WA; Cohen A; Lasonder E; Stunnenberg HG
    Mol Cell Biol; 2006 Feb; 26(3):843-51. PubMed ID: 16428440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The chromatin remodeler Chd4 maintains embryonic stem cell identity by controlling pluripotency- and differentiation-associated genes.
    Zhao H; Han Z; Liu X; Gu J; Tang F; Wei G; Jin Y
    J Biol Chem; 2017 May; 292(20):8507-8519. PubMed ID: 28298436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myeloid transforming protein Evi1 interacts with methyl-CpG binding domain protein 3 and inhibits in vitro histone deacetylation by Mbd3/Mi-2/NuRD.
    Spensberger D; Vermeulen M; Le Guezennec X; Beekman R; van Hoven A; Bindels E; Stunnenberg H; Delwel R
    Biochemistry; 2008 Jun; 47(24):6418-26. PubMed ID: 18500823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular architecture of nucleosome remodeling and deacetylase sub-complexes by integrative structure determination.
    Arvindekar S; Jackman MJ; Low JKK; Landsberg MJ; Mackay JP; Viswanath S
    Protein Sci; 2022 Sep; 31(9):e4387. PubMed ID: 36040254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mbd3/NuRD controls lymphoid cell fate and inhibits tumorigenesis by repressing a B cell transcriptional program.
    Loughran SJ; Comoglio F; Hamey FK; Giustacchini A; Errami Y; Earp E; Göttgens B; Jacobsen SEW; Mead AJ; Hendrich B; Green AR
    J Exp Med; 2017 Oct; 214(10):3085-3104. PubMed ID: 28899870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The methyl binding domain 3/nucleosome remodelling and deacetylase complex regulates neural cell fate determination and terminal differentiation in the cerebral cortex.
    Knock E; Pereira J; Lombard PD; Dimond A; Leaford D; Livesey FJ; Hendrich B
    Neural Dev; 2015 May; 10():13. PubMed ID: 25934499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Smek promotes corticogenesis through regulating Mbd3's stability and Mbd3/NuRD complex recruitment to genes associated with neurogenesis.
    Moon BS; Yun HM; Chang WH; Steele BH; Cai M; Choi SH; Lu W
    PLoS Biol; 2017 May; 15(5):e2001220. PubMed ID: 28467410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Embryonic Stem Cell-Specific NuRD Complex Functions through Interaction with WDR5.
    Ee LS; McCannell KN; Tang Y; Fernandes N; Hardy WR; Green MR; Chu F; Fazzio TG
    Stem Cell Reports; 2017 Jun; 8(6):1488-1496. PubMed ID: 28528697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MBD3, a component of the NuRD complex, facilitates chromatin alteration and deposition of epigenetic marks.
    Morey L; Brenner C; Fazi F; Villa R; Gutierrez A; Buschbeck M; Nervi C; Minucci S; Fuks F; Di Croce L
    Mol Cell Biol; 2008 Oct; 28(19):5912-23. PubMed ID: 18644863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MUC1-C Activates the NuRD Complex to Drive Dedifferentiation of Triple-Negative Breast Cancer Cells.
    Hata T; Rajabi H; Takahashi H; Yasumizu Y; Li W; Jin C; Long MD; Hu Q; Liu S; Fushimi A; Yamashita N; Kui L; Hong D; Yamamoto M; Miyo M; Hiraki M; Maeda T; Suzuki Y; Samur MK; Kufe D
    Cancer Res; 2019 Nov; 79(22):5711-5722. PubMed ID: 31519689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MBD3 localizes at promoters, gene bodies and enhancers of active genes.
    Shimbo T; Du Y; Grimm SA; Dhasarathy A; Mav D; Shah RR; Shi H; Wade PA
    PLoS Genet; 2013; 9(12):e1004028. PubMed ID: 24385926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NuRD blocks reprogramming of mouse somatic cells into pluripotent stem cells.
    Luo M; Ling T; Xie W; Sun H; Zhou Y; Zhu Q; Shen M; Zong L; Lyu G; Zhao Y; Ye T; Gu J; Tao W; Lu Z; Grummt I
    Stem Cells; 2013 Jul; 31(7):1278-86. PubMed ID: 23533168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low HOX gene expression in PML-RARα-positive leukemia results from suppressed histone demethylation.
    Rejlova K; Musilova A; Kramarzova KS; Zaliova M; Fiser K; Alberich-Jorda M; Trka J; Starkova J
    Epigenetics; 2018; 13(1):73-84. PubMed ID: 29224413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.